학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 8건 | 목록 1~20
Academic Journal
Bonetti A; Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.; Le VL; Department of Data and Digital Health Institut Bergonié, Bordeaux, France.; INRIA center at University of Bordeaux, Talence, France.; Bordeaux Mathematics Institute (IMB), CNRS UMR 5251, University of Bordeaux, Talence, France.; Carrero ZI; Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.; Wolf F; Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.; Gustav M; Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.; Lam SW; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Vanhersecke L; Department of Biopathology Institut Bergonié, Bordeaux, France.; Sobczuk P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Le Loarer F; Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, Institut Bergonié, 33000 Bordeaux, France.; Department of Biopathology Institut Bergonié, Bordeaux, France.; Lenarcik M; Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland.; Department of Cancer Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; van Sabben JM; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.; van Boven H; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Machado I; Department of Pathology, Instituto Valenciano de Oncología, Valencia. Spain.; Patologika Laboratory Hospital Quirón-Salud, Valencia. Spain.; Department of Pathology, University of Valencia. Spain.; CIBERONC(ISCIII), Madrid. Spain.; Bagué S; Department of Pathology, Hospital de la Santa Creu i Sant Pau. Barcelona. Spain.; Navarro S; Department of Pathology, University of Valencia. Spain.; INCLIVA,Valencia.; CIBERONC(ISCIII), Madrid. Spain.; Medina-Ceballos E; Department of Pathology, University of Valencia. Spain.; Agra C; Pathology Department HGU Gregorio Marañon (Madrid). Spain.; Giner F; Department of Pathology, University of Valencia. Spain.; Department of Pathology, Hospital Universitari i Politècnic La Fe, Valencia. Spain.; Tapia G; Department of Pathology. Hospital Universitari Germans Trias i Pujol. IGTP. Universitat Autònoma de Barcelona. Spain.; Hernández-Gallego A; Department of Pathology. Hospital Universitari Germans Trias i Pujol. IGTP. Universitat Autònoma de Barcelona. Spain.; Civantos Jubera G; Department of Pathology, Hospital Universitario Virgen del Rocío, Sevilla. Spain.; Cuatrecasas M; Pathology Department. Hospital Clinic, Barcelona. University of Barcelona. Barcelona. Spain.; Liver and Digestive Diseases Biomedical Research Center Network (CIBERehd).; Carlosiii Health Institute. Madrid. Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Barcelona, Spain.; Lopez-Prades S; University of Barcelona, Faculty of Medicine. Spain.; Pathology Department, Hospital Clinic Barcelona. Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Barcelona, Spain.; Perret RE; Department of Biopathology Institut Bergonié, Bordeaux, France.; Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, Institut Bergonié, 33000 Bordeaux, France.; Soubeyran I; Department of Biopathology Institut Bergonié, Bordeaux, France.; Khalifa E; Department of Biopathology Institut Bergonié, Bordeaux, France.; Blouin L; Department of Biopathology Institut Bergonié, Bordeaux, France.; Wardelmann E; Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Münster, Germany.; Meurgey A; Biopathology Department, Centre Léon Bérard, Unicancer, Lyon, France.; Collini P; Department of Advanced Diagnostics - Soft Tissue Tumor Pathology Unit - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Milan - Italy.; Voloshin A; Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Münster, Germany.; Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.; Hirano H; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy.; Nishida T; Department of Surgery, Japan Community Healthcare Organization Osaka Hospital, Osaka, Japan; Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.; Bouché O; Gastrointestinal Oncology Department. CHU Reims, Reims, France.; Emile JF; Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise-Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne, France.; Ngo C; Department of Pathology, Gustave Roussy, 94800 Villejuif, France.; Hohenberger P; Div. of Surgical Oncology, Mannheim University Medical Center, Medical Faculty Mannheim, University of Heidelberg, Germany.; Cotarelo C; Institute of Pathology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Jakob J; Department of Surgery, Sarcoma Unit, University Medical Center and Medical Faculty Mannheim, Heidelberg University, Germany.; Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Szumera-Cieckiewicz A; Biobank, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Jean-Denis M; Research and Innovation Department, Centre Léon Bérard, Unicancer, Lyon, France.; Bollard J; Research and Innovation Department, Centre Léon Bérard, Unicancer, Lyon, France.; Lassau N; Imaging Department. Gustave Roussy, 94800 Villejuif, France.; Lecesne A; Department of Medical Oncology Gustave Roussy, 94800 Villejuif, France.; Blay JY; Department of Medicine, Centre Leon Berard, & University Claude Bernard Lyon.; Italiano A; Department of Medicine Institut Bergonié, Bordeaux, France.; Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, Institut Bergonié, 33000 Bordeaux, France.; Crombé A; Department of Oncologic Imaging, Gustave Roussy, 94800, Villejuif, France.; Coindre JM; Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, Institut Bergonié, 33000 Bordeaux, France.; Department of Biopathology Institut Bergonié, Bordeaux, France.; Kather JN; Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.; Department of Medicine I, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany.; Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; Pathology & Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Electronic address: marco.donia@regionh.dk.; Jespersen H; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Jalving M; University Medical Centre Groningen, Groningen, The Netherlands.; Lee R; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Eriksson H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer Skin Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Hernberg M; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; Helsinki University, Helsinki, Finland.; Gavrilova I; University Hospital for Active Treatment of Oncology, Sofia, Bulgaria.; Kandolf L; Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.; Liszkay G; National Institute of Oncology, Budapest, Hungary; Middle-Eastern European Academy, Budapest, Hungary.; Helgadottir H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer Skin Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Zhukavets A; Department of Oncology, Belarusian State Medical University, Minsk, Belarus.; Pjanova D; Riga Stradins University, Riga, Latvia.; Marquez-Rodas I; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.; Neyns B; Universitair Ziekenhuis Brussel (UZ Brussel), Department of Medical Oncology, Brussels, Belgium.; Westgeest H; Amphia Hospital, Department of Internal Medicine, Breda, The Netherlands.; Pourmir I; European Georges Pompidou Hospital, Department of Thoracic Oncology, Paris, France; INSERM U970, Immunotherapy and Antiangiogenic Treatment in Oncology, Paris, France.; Sobczuk P; Maria Slodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland.; Ellebaek E; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Amaral T; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally InstructedTumor Therapies', Tübingen, Germany. Electronic address: Teresa.Amaral@med.uni-tuebingen.de.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE; In Process
Academic Journal
Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Electronic address: marco.donia@regionh.dk.; Jespersen H; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Jalving M; University Medical Centre Groningen, Groningen, The Netherlands.; Lee R; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Eriksson H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer Skin Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Hernberg M; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; Helsinki University, Helsinki, Finland.; Gavrilova I; University Hospital for Active Treatment of Oncology, Sofia, Bulgaria.; Kandolf L; Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.; Liszkay G; National Institute of Oncology, Budapest, Hungary; Middle-Eastern European Academy, Budapest, Hungary.; Helgadottir H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer Skin Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Zhukavets A; Department of Oncology, Belarusian State Medical University, Minsk, Belarus.; Pianova D; Riga Stradins University, Riga, Latvia.; Marquez-Rodas I; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.; Neyns B; Universitair Ziekenhuis Brussel (UZ Brussel), Department of Medical Oncology, Brussels, Belgium.; Westgeest H; Amphia Hospital, Department of Internal Medicine, Breda, The Netherlands.; Pourmir I; European Georges Pompidou Hospital, Department of Thoracic Oncology, Paris, France; INSERM U970, Immunotherapy and Antiangiogenic Treatment in Oncology, Paris, France.; Sobczuk P; Maria Slodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland.; Ellebaek E; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Amaral T; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Tübingen, Germany. Electronic address: Teresa.Amaral@med.uni-tuebingen.de.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Sobczuk P; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland. pawel.sobczuk@wum.edu.pl.; Trzcinska-Danielewicz J; Department of Molecular Biology, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Warsaw, Poland.; Koperski L; Department of Pathology, Medical University of Warsaw, Warsaw, Poland.; Girstun A; Department of Molecular Biology, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Warsaw, Poland.; Cudnoch-Jedrzejewska A; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Publisher: Polish Physiological Society Country of Publication: Poland NLM ID: 9114501 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1899-1505 (Electronic) Linking ISSN: 08675910 NLM ISO Abbreviation: J Physiol Pharmacol Subsets: MEDLINE
Academic Journal
Słowińska M; Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.; Dudzisz-Śledź M; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Sobczuk P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.; Łasińska I; Department of Medical and Experimental Oncology, Heliodor Święcicki Clinical Hospital, Poznań University of Medical Sciences, Poznań, Poland.; Department of Nursing, Institute of Medical Sciences, Collegium Medicum, University of Zielona Góra, Zielona Góra, Poland.; Pietruszka A; 1st Radiation and Clinical Oncology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.; Cybulska-Stopa B; Clinical Oncology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Cracow Branch, Cracow, Poland.; Kowalczyk A; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.; Świtaj T; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Czarnecka I; Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.; Koseła-Paterczyk H; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Rogala P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Paluchowska E; Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.; Składowski K; 1st Radiation and Clinical Oncology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.; Mackiewicz J; Department of Medical and Experimental Oncology, Heliodor Święcicki Clinical Hospital, Poznań University of Medical Sciences, Poznań, Poland.; Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznań, Poland.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Owczarek W; Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE
Editorial & Opinion
Crona J; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.; Lee R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Department of Cancer Sciences, Faculty Biology Medicine and Health, The University of Manchester, Manchester, UK.; Sobczuk P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Wysoki O; Department of Cancer Sciences, Faculty Biology Medicine and Health, The University of Manchester, Manchester, UK.; Devnani B; Department of Radiation Oncology, All India Institute of Medical Sciences, Jodhpur, India.; Prasongsook N; Department of Medical Oncology, Phramongkutklao Hospital, Bangkok, Thailand.; Scheffler M; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Jalving M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: m.jalving@umcg.nl.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Sobczuk P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw. Electronic address: pawel.sobczuk@nio.gov.pl.; Gawlik-Urban A; Clinical Oncology Department with Chemotherapy Subunit, Provincial Hospital Saint Luke, Tarnów; Faculty of Health Sciences, University of Applied Sciences in Tarnów, Tarnów.; Sigorski D; Department of Oncology, University of Warmia and Mazury, Olsztyn; Department of Oncology and Immuno-Oncology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration's Hospital, Olsztyn.; Kiszka J; Department of Clinical Oncology, Subcarpathian Cancer Center, Brzozów.; Osmola M; Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw.; Machulska-Ciuraj K; Department of Clinical Oncology and Chemotherapy, Independent Public Clinical Hospital No. 4, Lublin.; Wilk M; Oncology Department, ECZ-Postgraduate Medical Center European Health Center, Otwock.; Brodziak A; Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw; Laboratory of Centre for Preclinical Research, Department of Experimental and Clinical Physiology, Medical University of Warsaw, Warsaw, Poland.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Report
Lim KHJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK. Electronic address: jonathan.lim@doctors.org.uk.; Westphalen CB; Department of Internal Medicine III, University Hospital LMU Munich, Comprehensive Cancer Centre Munich and German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Cardone C; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy.; Connolly EA; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia.; Güven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.; Kfoury M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; Kocakavuk E; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany.; Mandó P; Clinical Oncology Department, Centro de Educación Médica e Investigaciones Clínicas 'Norberto Quirno' (CEMIC), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.; Mariamidze E; Todua Clinic Department of Oncology and Haematology, Tbilisi, Georgia.; Matikas A; Breast Center, Karolinska Comprehensive Cancer Center, Stockholm, Sweden.; Moutafi M; Department of Oncology, Attikon University Hospital, Athens, Greece.; Oing C; Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK; Mildred Scheel Cancer Career Centre HaTriCS4, University Cancer Centre Hamburg, University Medical Centre Eppendorf, Hamburg, Germany.; Pihlak R; Medical Oncology Department, St Bartholomew's Hospital, London, UK.; Punie K; Department of Medical Oncology, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium.; Sánchez-Bayona R; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Sobczuk P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Starzer AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Tečić Vuger A; Breast Cancer Unit, Medical Oncology Department, University Hospital for Tumors, Sestre Milosrdnice University Hospital Centre, Zagreb, Croatia.; Zhu H; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Cruz-Ordinario MVB; Section of Medical Oncology, Cancer Institute, St. Luke's Medical Center, Quezon City, Metro Manila, the Philippines.; Altuna SC; Department of Medical Oncology, Oncomédica, Caracas, Venezuela.; Canário R; Cancer Metastasis, i3S-Institute for Research & Innovation in Health, Porto; Research Centre, Portuguese Oncology Institute of Porto, Porto; ICBAS, School of Medicine and Biomedical Sciences, Porto, Portugal.; Vuylsteke P; Department of Internal Medicine, University of Botswana, Gaborone, Botswana.; Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London; The Institute of Cancer Research, London, UK.; de Azambuja E; Institut Jules Bordet and L'Université Libre de Bruxelles (ULB), Brussels, Belgium.; Cervantes A; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid; Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), Universidad Valencia, Valencia, Spain.; Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa; Department of Medical Oncology, U.O. Clinical di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Campus, Barcelona, Spain.; Amaral T; Centre for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen; Cluster of Excellence IFIT (EXC2180), Tübingen, Germany.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Sobczuk, P
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어